Search PDMR transactions

Notifier
Name of person with notification obligation
Viktor Siewertz
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Viktor Siewertz
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
IRLAB Therapeutics AB
Issuer´s LEI code
549300JAT34LHEI0DH60
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 3,000 Quantity 38.93 SEK 27/05/2022 NASDAQ STOCKHOLM AB
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 3,000 Quantity 40.16 SEK 30/05/2022 NASDAQ STOCKHOLM AB
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 4,500 Quantity 37.86 SEK 31/05/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 27/05/2022 NASDAQ STOCKHOLM AB 3,000 (Quantity) 38.93 SEK
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 30/05/2022 NASDAQ STOCKHOLM AB 3,000 (Quantity) 40.16 SEK
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 31/05/2022 NASDAQ STOCKHOLM AB 4,500 (Quantity) 37.86 SEK
Total: 10,500
<< Back